Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyral Dose Response Study in Contact Dermatitis
NCT02028182Phase 2Completed
- Sponsor
- Allerderm Laboratories, Inc.
- Start
- Feb 2013
- Primary completion
- Jun 2013
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in contact dermatitis, sponsored by Allerderm Laboratories, Inc. Primary endpoint: Number of Participants With Positive Patch Test Responses at 21 days. Started Feb 2013; status: completed.
02
Conditions
contact dermatitis
Beyond the preview
Go deeper on NCT02028182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028182.